HSA — authorised 4 September 2014
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
🇸🇬 Keytruda in Singapore
HSA authorised Keytruda on 4 September 2014
Marketing authorisations
HSA — authorised 28 April 2020
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
HSA — authorised 21 November 2025
- Marketing authorisation holder: MERCK SHARP DOHME
- Status: likely_approved
Keytruda in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Keytruda approved in Singapore?
Yes. HSA authorised it on 4 September 2014; HSA authorised it on 28 April 2020; HSA authorised it on 21 November 2025.
Who is the marketing authorisation holder for Keytruda in Singapore?
MERCK SHARP DOHME holds the Singaporean marketing authorisation.